New centre plans to improve understanding of neural diseases Can early exposure to anti-TNF therapy reduce the risk of Parkinson disease?Study suggests reducing systemic inflammation in patients with inflammatory bowel disease can also decrease the incidence of Parkinson disease Can the healthy brain offer clues to curing Alzheimer's? Management of migraine in children and adolescents Many therapies effective in adults have not been adequately studied in children. Ocrevus receives conditional approval for use in early primary progressive MS Intravenous monoclonal antibody originally approved only for use in relapsing remitting multiple sclerosis (MS) CGRP antagonists: new migraine prevention therapies in current development Monoclonal antibodies targeting the calcitonin gene-related peptide pathway are under study for preventing episodic and chronic migraine Outcomes in newly diagnosed epilepsy have not improved over the past 20 years Despite availability of newer drugs, epilepsy still uncontrolled in more than one-third of patients New autism research centre to be created thanks to $16M donation Hints that lifestyle changes might guard against dementia No benefit from long-term opioid therapy for patients with polyneuropathy Increased risk of depression, opioid dependence and opioid overdose, without any improvement in functional status First Previous 25 26 27 28 29 Next Last
